Dominik Wolf‎

18.8k total citations · 2 hit papers
287 papers, 9.0k citations indexed

About

Dominik Wolf‎ is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Dominik Wolf‎ has authored 287 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Hematology, 92 papers in Genetics and 79 papers in Oncology. Recurrent topics in Dominik Wolf‎'s work include Chronic Myeloid Leukemia Treatments (52 papers), Chronic Lymphocytic Leukemia Research (47 papers) and Immune Cell Function and Interaction (38 papers). Dominik Wolf‎ is often cited by papers focused on Chronic Myeloid Leukemia Treatments (52 papers), Chronic Lymphocytic Leukemia Research (47 papers) and Immune Cell Function and Interaction (38 papers). Dominik Wolf‎ collaborates with scholars based in Austria, Germany and United States. Dominik Wolf‎'s co-authors include Anna Wolf, Holger Rumpold, Eberhard Gunsilius, Herbert Tilg, Guenther Gastl, Barbara Enrich, Andreas Pircher, Sieghart Sopper, Michael Steurer and Andreas Fellgiebel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Dominik Wolf‎

270 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes

2004 667 citations Anna Wolf, Dominik Wolf‎ et al. profile →
Increase of regulatory T cells in the peripheral blood of cancer patients.

2003 534 citations Dominik Wolf‎, Eberhard Gunsilius et al. profile →

Peers

Countries citing papers authored by Dominik Wolf‎

Since Specialization

Citations

This map shows the geographic impact of Dominik Wolf‎'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Wolf‎ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Wolf‎ more than expected).

Fields of papers citing papers by Dominik Wolf‎

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Wolf‎. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Wolf‎. The network helps show where Dominik Wolf‎ may publish in the future.

Co-authorship network of co-authors of Dominik Wolf‎

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Wolf‎. A scholar is included among the top collaborators of Dominik Wolf‎ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Wolf‎. Dominik Wolf‎ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Tim H. Brümmendorf, Steffen Koschmieder, Martin Grießhammer, Ines Gütgemann, (unknown), T Fischer, Peter Brossart, (unknown), Eicke Latz, Dominik Wolf‎, Lino L. Teichmann	0
2	Profiling low-mRNA content cells in complex human tissues using BD Rhapsody single-cell analysis 2024 ·STAR Protocols ·(unknown), Manuel Trebo, (unknown), Isabel Heidegger, Theresa Hautz, Rupert Oberhuber, Zlatko Trajanoski, Florian Augustin, Sieghart Sopper, Dominik Wolf‎, Andreas Pircher, Stefan Salcher	2
3	Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature 2024 ·European Urology Oncology ·Isabel Heidegger, (unknown), Stefan Salcher, Piotr Tymoszuk, Agnieszka Martowicz, Enrique Gómez‐Gómez, Ana Blanca, (unknown), (unknown), (unknown), (unknown), (unknown), Friedrich Aigner, Martin Puhr, Anne Krogsdam, Zlatko Trajanoski, Dominik Wolf‎, (unknown)	9
4	530P Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study 2024 ·Annals of Oncology ·Andreas Seeber, (unknown), Bernhard Doleschal, Hossein Taghizadeh, (unknown), Florian Moik, (unknown), Ludwig Wagner, (unknown), (unknown), (unknown), Arno Amann, Dominik Wolf‎, Richard Greil, Philipp J. Jost, Thomas Winder, Holger Rumpold, (unknown), Armin Gerger, Jakob M. Riedl	0
5	Impact of TP53 Mutation on Outcome after Allogeneic Stem Cell Transplantation for Patients with MDS/AML Not in Complete Remission 2024 ·Blood ·Normann Steiner, Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, (unknown), David Nachbaur, Dominik Wolf‎, Nico Gagelmann, Christian Niederwieser, (unknown), (unknown), Christine Wolschke, Francis Ayuk, (unknown)	1
6	Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Dominik Wolf‎, Zoltán Bánki, (unknown), (unknown), G. Carl Huber, (unknown), Christian Thirion, Heribert Stoiber	2
7	Antibiotic Prophylaxis During Allogeneic Stem Cell transplantation—A Comprehensive Single Center Retrospective Analysis 2024 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), (unknown), M. Schumacher, (unknown), (unknown), Dominik Wolf‎, Peter Brossart, Tobias A.W. Holderried	4
8	Multidisciplinary Treatment of Liver Metastases from Intracranial SFTs/HPCs: A Report of Three Consecutive Cases 2022 ·Current Oncology ·(unknown), Franka Messner, Gregor Laimer, Angela Djanani, Andreas Seeber, Georg Oberhuber, Dietmar Öfner, Dominik Wolf‎, Stefan Schneeberger, Reto Bale, Christian Margreiter	2
9	Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma 2022 ·European Journal Of Haematology ·(unknown), Emina Jukic, (unknown), Markus A. Keller, (unknown), (unknown), (unknown), Irmgard Verdorfer, (unknown), Martina Witsch‐Baumgartner, David Nachbaur, Wolfgang Willenbacher, Eberhard Gunsilius, Dominik Wolf‎, Johannes Zschocke, Normann Steiner	6
10	The cancer patient’s perspective of COVID‐19‐induced distress—A cross‐sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic 2021 ·Cancer Medicine ·Karin A. Koinig, C. Arnold, Jens Lehmann, Johannes M. Giesinger, (unknown), Wolfgang Willenbacher, (unknown), Bernhard Holzner, Ute Ganswindt, Dominik Wolf‎, Reinhard Stauder	29
11	The Biology of Classic Hairy Cell Leukemia 2021 ·International Journal of Molecular Sciences ·(unknown), Stefan Salcher, Andreas Pircher, Gerold Untergasser, Dominik Wolf‎	9
12	Helios-expressing CD8 ⁺ T cells are decreased in patients with systemic lupus erythematosus 2021 ·Lupus ·Tobias A.W. Holderried, (unknown), (unknown), Peter Brossart, Dominik Wolf‎, Anna Wolf	4
13	Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis 2021 ·memo - Magazine of European Medical Oncology ·(unknown), (unknown), Eberhard Gunsilius, Andreas Chott, Andreas Peer, (unknown), Gernot Fritsche, Michael Joannidis, Dominik Wolf‎, Andreas Pircher	0
14	The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis 2020 ·Cancers ·Normann Steiner, Karin Jöhrer, (unknown), (unknown), Georg Göbel, David Nachbaur, Dominik Wolf‎, Eberhard Gunsilius, Gerold Untergasser	4
15	Curcumin: New Insights into an Ancient Ingredient against Cancer 2019 ·International Journal of Molecular Sciences ·Ella Willenbacher, Shah Zeb Khan, (unknown), Dario Trapani, (unknown), Dominik Wolf‎, Wolfgang Willenbacher, Gilbert Spizzo, Andreas Seeber	121
16	Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy 2016 ·Clinical Cancer Research ·Noortje Thielen, Johan Richter, (unknown), Gisela Barbany, Thoas Fioretos, Francis J. Giles, Bjørn Tore Gjertsen, Andreas Hochhaus, Gerrit Jan Schuurhuis, Sieghart Sopper, Leif Stenke, Sarah Thunberg, Dominik Wolf‎, Gert J. Ossenkoppele, Kimmo Porkka, Jeroen J. W. M. Janssen, Satu Mustjoki	14
17	Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis 2015 ·Gut ·Sabine Klein, (unknown), Jennifer Lehmann, Robert Schierwagen, (unknown), Len Verbeke, Kanishka Hittatiya, Frank Erhard Uschner, Steffen Manekeller, Christian P. Strassburg, Kay‐Uwe Wagner, Peter P. Sayeski, Dominik Wolf‎, Wim Laleman, Tilman Sauerbruch, Jonel Trebicka	55
18	JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms 2015 ·Cancer Research ·Kathrin Schönberg, Janna Rudolph, (unknown), Sowmya Parampalli Yajnanarayana, Isabelle Cornez, Maryam Hejazi, Angela R. Manser, Markus Uhrberg, Walter Verbeek, Steffen Koschmieder, Tim H. Brümmendorf, Peter Brossart, Annkristin Heine, Dominik Wolf‎	123
19	The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo 2009 ·The Journal of Immunology ·Anna Wolf, Kathrin Eller, Robert Zeiser, Christoph Dürr, U. Gerlach, Michael Sixt, (unknown), Guenther Gastl, Alexander R. Rosenkranz, Dominik Wolf‎	48
20	TNF-α-Induced Expression of Adhesion Molecules in the Liver Is Under the Control of TNFR1—Relevance for Concanavalin A-Induced Hepatitis 2001 ·The Journal of Immunology ·Dominik Wolf‎, Rupert Hallmann, Gabriele Sass, Michael Sixt, Sabine Küsters, (unknown), Christian Trautwein, Gisa Tiegs	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact